Yaxi Chen

2.5k total citations · 2 hit papers
50 papers, 1.9k citations indexed

About

Yaxi Chen is a scholar working on Epidemiology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yaxi Chen has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 22 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Yaxi Chen's work include Liver Disease Diagnosis and Treatment (17 papers), Peroxisome Proliferator-Activated Receptors (11 papers) and Cancer, Lipids, and Metabolism (10 papers). Yaxi Chen is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Peroxisome Proliferator-Activated Receptors (11 papers) and Cancer, Lipids, and Metabolism (10 papers). Yaxi Chen collaborates with scholars based in China, United Kingdom and United States. Yaxi Chen's co-authors include Xiong Z. Ruan, Zac Varghese, John F. Moorhead, Lei Zhao, Ping Yang, Stephen H. Powis, Han Zeng, Kun Liu, Wei Li and Ping Yang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yaxi Chen

48 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis

2022 201 citations Ping Yang, Hong Qin et al. Nature Communications profile →
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma

2023 136 citations Yaxi Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yaxi Chen China	18	867	565	544	290	283	50	1.9k
Aijuan Qu China	32	1.3k 1.5×	662 1.2×	596 1.1×	270 0.9×	300 1.1×	66	2.9k
Pierluigi Ramadori Germany	25	644 0.7×	656 1.2×	332 0.6×	213 0.7×	208 0.7×	42	1.8k
Marta Casado Spain	28	1.0k 1.2×	449 0.8×	369 0.7×	234 0.8×	442 1.6×	75	2.3k
Prasanna K. Santhekadur India	23	994 1.1×	784 1.4×	369 0.7×	161 0.6×	226 0.8×	57	2.1k
Marta B. Afonso Portugal	18	734 0.8×	681 1.2×	419 0.8×	113 0.4×	187 0.7×	44	1.4k
Fausto Andreola United Kingdom	25	861 1.0×	649 1.1×	226 0.4×	163 0.6×	312 1.1×	55	1.9k
Réjane Paumelle France	22	1.0k 1.2×	578 1.0×	214 0.4×	203 0.7×	350 1.2×	31	1.9k
Wen‐Lung Ma Taiwan	23	839 1.0×	277 0.5×	480 0.9×	112 0.4×	216 0.8×	68	1.9k
Bingning Dong United States	20	837 1.0×	578 1.0×	342 0.6×	102 0.4×	514 1.8×	30	2.0k
Barbara Gross France	18	1.1k 1.2×	483 0.9×	191 0.4×	299 1.0×	409 1.4×	31	2.3k

Countries citing papers authored by Yaxi Chen

Since Specialization

Citations

This map shows the geographic impact of Yaxi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaxi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaxi Chen more than expected).

Fields of papers citing papers by Yaxi Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaxi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaxi Chen. The network helps show where Yaxi Chen may publish in the future.

Co-authorship network of co-authors of Yaxi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yaxi Chen. A scholar is included among the top collaborators of Yaxi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaxi Chen. Yaxi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yun, et al.. (2025). Selenoprotein K-dependent MyD88 palmitoylation promotes hepatic metaflammation in high-fat diet fed mice. Free Radical Biology and Medicine. 236. 144–159.

Hu, Ke, Ping Wang, Yunfei Zhao, et al.. (2025). Hypoxia-responsive modules via tunable hydrophobicity reversal enhance renal-targeted release of CD36-interfering nanoparticles to ameliorate acute kidney injury. Journal of Controlled Release. 389. 114453–114453.

Qin, Hong, Xiaoqing Luo, Enze Zheng, et al.. (2024). The fatty acid receptor CD36 promotes macrophage infiltration via p110γ signaling to stimulate metastasis. Journal of Advanced Research. 74. 237–253. 9 indexed citations

Zheng, Enze, Qianqian Chen, Xiaoqing Luo, et al.. (2024). Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway. Biochemical and Biophysical Research Communications. 707. 149781–149781. 1 indexed citations

Zhao, Yunfei, Ke Hu, Yu‐Feng Su, et al.. (2024). Guanidine‐Derived Polymeric Nanoinhibitors Target the Lysosomal V‐ATPase and Activate AMPK Pathway to Ameliorate Liver Lipid Accumulation. Advanced Science. 12(1). e2408906–e2408906. 4 indexed citations

Chen, Yaxi, et al.. (2023). The association of soluble cluster of differentiation 36 with metabolic diseases: A potential biomarker and therapeutic target. SHILAP Revista de lepidopterología. 1(1). e9–e9. 1 indexed citations

Tang, Dan, Chun Loo Gan, Mi Bai, et al.. (2023). Novel variants in CRB2 targeting the malfunction of slit diaphragm related to focal segmental glomerulosclerosis. Pediatric Nephrology. 39(1). 149–165. 3 indexed citations

Guo, Zheng, Wei Li, Yizhe Wang, et al.. (2023). SCAP contributes to embryonic angiogenesis by negatively regulating KISS-1 expression in mice. Cell Death and Disease. 14(4). 249–249. 3 indexed citations

Wu, Fan, Mengyue Chen, Yun Li, et al.. (2022). Inhibition of Fatty Acid Translocase (FAT/CD36) Palmitoylation Enhances Hepatic Fatty Acid β-Oxidation by Increasing Its Localization to Mitochondria and Interaction with Long-Chain Acyl-CoA Synthetase 1. Antioxidants and Redox Signaling. 36(16-18). 1081–1100. 86 indexed citations

10.

Chen, Yaxi, et al.. (2022). Development and validation of a CT-based nomogram to predict spread through air space (STAS) in peripheral stage IA lung adenocarcinoma. Japanese Journal of Radiology. 40(6). 586–594. 17 indexed citations

11.

Zeng, Han, Hong Qin, Enze Zheng, et al.. (2022). HIF-2α-induced upregulation of CD36 promotes the development of ccRCC. Experimental Cell Research. 421(2). 113389–113389. 14 indexed citations

12.

Yang, Ping, Hong Qin, Yiyu Li, et al.. (2022). CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nature Communications. 13(1). 5782–5782. 201 indexed citations breakdown →

13.

Chen, Yaxi, et al.. (2020). Detrimental effects of hypercortisolism on brain structure and related risk factors. Scientific Reports. 10(1). 12708–12708. 19 indexed citations

14.

Li, Zhe, Danyang Li, Li Wei, et al.. (2020). SCAP knockout in SM22α-Cre mice induces defective angiogenesis in the placental labyrinth. Biomedicine & Pharmacotherapy. 133. 111011–111011. 7 indexed citations

15.

Yang, Ping, Xuan Luo, Han Zeng, et al.. (2018). Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src/ERK pathway. Cancer Letters. 438. 76–85. 108 indexed citations

16.

Zhao, Lei, Xiaoxiao Luo, Pei Wang, et al.. (2018). CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. Journal of Hepatology. 69(3). 705–717. 232 indexed citations

17.

Yang, Xiaochun, Daryl M. Okamura, Xifeng Lu, et al.. (2017). CD36 in chronic kidney disease: novel insights and therapeutic opportunities. Nature Reviews Nephrology. 13(12). 769–781. 198 indexed citations

18.

Wu, Wei, Lei Zhao, Ping Yang, et al.. (2016). Inflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/- Mice. PLoS ONE. 11(7). e0159512–e0159512. 20 indexed citations

19.

Yang, Ping, Yunfei Zhao, Lei Zhao, et al.. (2015). Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo. Scientific Reports. 5(1). 14959–14959. 17 indexed citations

20.

Wang, Chuan, Lin Hu, Lei Zhao, et al.. (2014). Rapamycin-mediated CD36 translational suppression contributes to alleviation of hepatic steatosis. Biochemical and Biophysical Research Communications. 447(1). 57–63. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact